Drawing for BIOSTEALTH

USPTO serial 79434375

BIOSTEALTH

Reviewed by CopyMark Law Group

Reg. 8428588Status 700Registered
Filing date
Status date
Registration date
Sep 15, 2026
Examiner
HENRY, NAKIA D
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIOSTEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miki Motohashi Iino

Miki Motohashi Iino Millen, White, Zelano & Branigan, P.C.2200 Clarendon Boulevard Suite 1400Arlington, VA 22201United States

Goods and services

ClassDescriptionStatusFirst use
010Stents; catheters; cardiac pacemakers; defibrillators; therapeutic apparatus and instruments, namely stents, implantable scaffolds comprising artificial materials for maintaining tissue contour and medical devices for opening the narrowed section of the lumen; medical guidewires; nanorobots for medical purposes for targeted drug delivery in blood vessels and prevention or treatment of thrombosis and stenosis; drug-coated stents for thrombosis; implantable subcutaneous drug delivery devices, namely implantable drug delivery pumps and implantable drug delivery ports; medical apparatus and instruments, namely cardiovascular, endovascular and implantable medical devices and structural medical apparatus, in particular stents, stent grafts, coils, artificial heart valves, artificial hearts, heart-lung machines (cardiopulmonary bypass apparatus), catheters, guidewires, and stent delivery systems, all for structural support, implantation, or circulation management in the human bodyACTIVE—
042Medical research; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Sep 15, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 15, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 15, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 21, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 21, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2026GPNXNOTIFICATION PROCESSED BY IB—
Jul 15, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 1, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 1, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 18, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 18, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 18, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Jun 18, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 18, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
May 23, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 22, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 22, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 18, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 18, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 18, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 18, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 12, 2026RFNTREFUSAL PROCESSED BY IB—
Feb 20, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 20, 2026RFRRREFUSAL PROCESSED BY MPU—
Jan 29, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 27, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 26, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 23, 2026DOCKASSIGNED TO EXAMINER—
Oct 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 9, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance